Sessa Capital IM »

SAB Biotherapeutics shares owned by Sessa Capital IM

Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Sessa Capital IM from 13F filings

Historical chart of Sessa Capital IM investment in SAB Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including SAB Biotherapeutics held by Sessa Capital IM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SAB Biotherapeutics by Sessa Capital IM

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 4.6M 0.69

More positions owned by Sessa Capital IM

Tesla Motors Put Option (TSLA)
Kellogg Company (K)
Garrett Motion (GTX)
Fortrea Hldgs Common Stock (FTRE)
Warner Bros Discovery Com Ser A (WBD)
Equitable Holdings (EQH)
Ally Financial (ALLY)
First Ctzns Bancshares Inc N Cl A (FCNCA)
At&t (T)
Walgreen Boots Alliance (WBA)
Us Foods Hldg Corp call (USFD)
Perrigo SHS (PRGO)
International Flavors & Fragrances (IFF)
Flex Ord (FLEX)
Tegna (TGNA)

View all positions for Sessa Capital IM

Top funds holding SAB Biotherapeutics

BVF
Sessa Capital IM
Vanguard Group
Pathstone Holdings
Institutional & Family Asset Management
Kestra Advisory Services
Mariner Wealth Advisors
Silver Oak Securities
Creative Planning
Advisor Group Holdings
Citadel Advisors
Charles Schwab Investment Management
Baird Financial
1st Source Bank
Spectrum Wealth Counsel

View all funds holding SAB Biotherapeutics